Back to Trials
NCT05766384Recruiting

Hyperpolarized 129Xe MRI Lung Health Cohort

University of Kansas Medical Center

Start Date

11/30/2023

Completion Date

3/31/2027

Summary

A subset of young adults participating in the American Lung Association (ALA) Lung Health Cohort (LHC) will be imaged using Hyperpolarized 129Xe MRI to assess lung structure and function. Images will be used to improve the understanding of lung health and early lung abnormalities that may lead to chronic lung disease.

Eligibility Criteria

Age Range: 25 years to 35 years

Inclusion Criteria: * Is enrolled in the American Lung Association Lung Health Cohort Study. * Has completed CT imaging for the LHC study within 2 years of the scheduled Xe-MRI date. Exclusion Criteria: * Pacemaker, internal defibrillator or other implanted electronic devices or any standard MRI contraindications (e.g., claustrophobia, \> 140 cm shoulder circumference, dependent on weight distribution). * Is pregnant or breastfeeding * Oxygen saturation (SpO2) \<88% on room air or with supplemental oxygen.

Interventions

DRUG

Hyperpolarized Xe129

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Healthy

Locations

University of Illinois-Chicago

Chicago, Illinois 60607

United States

University of Iowa

Iowa City, Iowa 52242

United States

University of Kansas Medical Center

Kansas City, Kansas 66160

United States

Duke University

Durham, North Carolina 27708

United States

Baylor College of Medicine

Houston, Texas 77030

United States

MD Anderson Cancer Center

Houston, Texas 77030

United States